3.00 credits
30.0 h + 15.0 h
Q2
Teacher(s)
Al Houayek Mireille (compensates Bindels Laure); Bindels Laure; Frédérick Raphaël; Henrard Séverine; Jacqmin Philippe; Jacqmin Philippe (compensates Bindels Laure); Leclercq Joëlle; Van Bambeke Françoise (coordinator);
Language
French
> English-friendly
> English-friendly
Main themes
- Definition of drug targets in the context of physiopathology and in a economical and societal perspective
- Discovery methods
- Steps of preclinical and clinical development
-Registration and refund by social security
-Pharmacovigilance
- Discovery methods
- Steps of preclinical and clinical development
-Registration and refund by social security
-Pharmacovigilance
Learning outcomes
At the end of this learning unit, the student is able to : | |
| 1 |
Analysis and understanding of the successive steps leading to the discovery, the preclinical and clinical development, and the commercialization of drugs. Knowledge of the process for integrating it in professional activities |
Content
2h sessions centered on one specific aspect, with description and analysis of the considered aspects and examples taken from drug development history.
Evaluation methods
individual (or small group) work, aiming at proposing the development plan of a fictive drug;, to be presented and defended orally
Teaching materials
- Diaporamas mis à disposition des étudiants + répertoire commenté des médicaments disponible online
Faculty or entity
FARM
Programmes / formations proposant cette unité d'enseignement (UE)
Title of the programme
Sigle
Credits
Prerequisites
Learning outcomes
Master [120] in Pharmacy
